Enlivex Therapeutics Ltd (ENLV NASDAQ) stock market data APIs
$0.8175
0.03(3.7%)
as of May 1, 2026
Try our APIs with
free plan!
Enlivex Therapeutics Ltd Financial Data Overview
Price chart is built with
Anychart
Enlivex Ltd., together with its subsidiaries, operates as a clinical-stage macrophage reprogramming immunotherapy company in Israel. It offers AllocetraTM, a cell therapy designed to restore macrophage homeostasis, as well as develops AllocetraTM intra-articular injection for the treatment of knee osteoarthritis, which is in phase 1/2 trial; intra-articular AllocetraTM in osteoarthritis of the temporomandibular joint (TMJ); and Allocetra-OTS for the treatment of organ failure in adult sepsis patients, which is in phase 2. Enlivex Ltd. was formerly known as Enlivex Therapeutics Ltd. and changed its name to Enlivex Ltd. in February 2026. The company was founded in 2005 and is headquartered in Ness Ziona, Israel.
Prev. Close
0.8175
Open
0.8441
High
0.8608
Low
0.7924
52 wk Range
0.66-2.1
Market Cap
197 M
P/E Ratio
0.032
Shares Outstanding
241 M
EPS
-0.0514
Beta
1.682
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Enlivex Therapeutics Ltd data using free add-ons & libraries
Get Enlivex Therapeutics Ltd Fundamental Data
Enlivex Therapeutics Ltd Fundamental data includes:
- Net Revenue:
- EBITDA: -14 668 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get Enlivex Therapeutics Ltd Earnings data
Corporate Events Calendar & News package for
$
19.99
/mo.
What’s included:
- Latest Release: 2026-02-25
- EPS/Forecast: -0.1426
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Enlivex Therapeutics Ltd News
New
Enlivex Therapeutics Q4 Earnings Call Highlights
Enlivex Therapeutics logo Key Points Enlivex reported $1.23 billion in net income and $25.48 diluted EPS for 2025, ending the year with $2.31 billion in treasury assets and $1.93 billion in sharehol...
Nasdaq biotech firm bets $212m on new Arbitrum-based prediction market
Prediction markets may be booming, but that’s not what’s sent Rain Protocol’s native token soaring 100% over the last 4 hours. On Monday, Enlivex, a Nasdaq-listed biopharma company, said it wou...
Enlivex anuncia una colocación privada de $212,000,000 para iniciar la primera estrategia de tesorería de activos digitales basada en mercados de predicción en el mundo, mediante la acumulación del token RAIN, y el nombramiento de Matteo Renzi, ex Primer Ministro de Italia, como miembro de su directorio.
- Tras el cierre de la colocación privada, Enlivex adoptará la primera estrategia de tesorería de activos digitales basada en mercados de predicción del mundo, mediante la acumulación del token R...
Enlivex mengumumkan Penempatan Persendirian bernilai AS$212,000,000 untuk Memulakan Strategi Perbendaharaan Aset Digital Pasaran Ramalan Pertama di Dunia, melalui Pengumpulan token RAIN, serta Pelantikan Matteo Renzi, Bekas Perdana Menteri Itali, ke dalam Lembaga Pengarahnya
- Selepas penutupan penempatan persendirian, Enlivex akan mengguna pakai strategi perbendaharaan aset digital token pasaran ramalan RAIN pertama di dunia melalui pengumpulan token RAIN. - RAIN ialah ...
Get Enlivex Therapeutics Ltd fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
